Trademark Overview
On Thursday, October 16, 2025, a trademark application was filed for RILMOBLI with the United States Patent and Trademark Office. The USPTO has given the RILMOBLI trademark a serial number of 99446203. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Tuesday, January 13, 2026. This trademark is owned by Sanofi. The RILMOBLI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of autoimmune, immune-mediated, immune-system related, inflammatory, and neurological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of rare autoimmune, rare immune-mediated, rare immune-system related, rare inflammatory, and rare neurological diseases and disorders